Compartmentalisation of EGFR signalling might potentiate the optimal use of EGFR tyrosine kinase inhibitors in cancer therapeutics

por Karamouzis, M V, Konstantinopoulos, P A, Papavassiliou, A G
Publicado 2007

Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer

por Launonen, I.-M., Lyytikäinen, N., Casado, J., Anttila, E. A., Szabó, A., Haltia, U.-M., Jacobson, C. A., Lin, J. R., Maliga, Z., Howitt, B. E., Strickland, K. C., Santagata, S., Elias, K., D’Andrea, A. D., Konstantinopoulos, P. A., Sorger, P. K., Färkkilä, A.
Publicado 2022